IHI:NYE-iShares U.S. Medical Devices ETF (USD)

ETF | Health |

Last Closing

USD 59.04

Change

-0.38 (-0.64)%

Market Cap

N/A

Volume

0.26M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.31 (-0.20%)

USD 42.10B
FHLC Fidelity® MSCI Health Care In..

-0.12 (-0.16%)

USD 3.01B
FXH First Trust Health Care AlphaD..

-0.50 (-0.45%)

USD 1.29B
XHE SPDR® S&P Health Care Equipme..

-0.47 (-0.52%)

USD 0.23B
IDNA iShares Genomics Immunology an..

+0.10 (+0.41%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

-0.19 (-0.49%)

USD 0.12B
XHS SPDR® S&P Health Care Service..

-0.39 (-0.40%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.06 (+0.19%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-0.08 (-0.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.16 (+0.55%)

USD 0.01B

ETFs Containing IHI

ETAC:CA 0.00 % 1.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.39% 52% F 53% F
Dividend Return 0.16% 31% F 2% F
Total Return 9.55% 52% F 46% F
Trailing 12 Months  
Capital Gain 22.31% 81% B- 62% D
Dividend Return 0.38% 39% F 4% F
Total Return 22.69% 81% B- 54% F
Trailing 5 Years  
Capital Gain 43.64% 43% F 67% D+
Dividend Return 2.32% 44% F 7% C-
Total Return 45.96% 43% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.41% 52% F 60% D-
Dividend Return 6.80% 52% F 53% F
Total Return 0.40% 47% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 19.82% 43% F 52% F
Risk Adjusted Return 34.34% 52% F 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.